Vir Biotechnology, Inc. (VIR) Net margin 2017–2025
Vir Biotechnology, Inc. (VIR) net profit margin by fiscal year — reported net income divided by reported revenue.
-638.9%FY2025 · since FY2017: -2579.5% → -638.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -638.9% | +64.5 pp |
| FY2024 | -703.4% | +10.3 pp |
| FY2023 | -713.7% | -745.6 pp |
| FY2022 | 31.9% | -16.3 pp |
| FY2021 | 48.3% | +439.3 pp |
| FY2020 | -391.1% | +1767.9 pp |
| FY2019 | -2159.0% | -1072.7 pp |
| FY2018 | -1086.3% | +1493.2 pp |
| FY2017 | -2579.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice